Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12132)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Martini G, Troiani T, Cardone C, Vitiello P, Sforza V, Ciardiello D, Napolitano S, Della Corte CM, Morgillo F, Raucci A, Cuomo A, Selvaggi F, Ciardiello F, Martinelli E. Present and future of metastatic colorectal cancer treatment: A review of new candidate targets. World J Gastroenterol 2017; 23(26): 4675-4688 [PMID: 28765689 DOI: 10.3748/wjg.v23.i26.4675] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v23/i26/4675.htm |
| Number | Citing Articles |
| 1 |
María Julia Martín, Pamela Azcona, Verónica Lassalle, Claudia Gentili. Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells. European Journal of Pharmaceutical Sciences 2021; 158: 105681 doi: 10.1016/j.ejps.2020.105681
|
| 2 |
E Fiegle, D Doleschel, S Koletnik, A Rix, R Weiskirchen, E Borkham-Kamphorst, F Kiessling, W Lederle. Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer. Neoplasia 2019; 21(9): 932 doi: 10.1016/j.neo.2019.07.006
|
| 3 |
Junyue Chen, Tingting Fan, Yan Chen, Lizhen Ye, Chen Zhang, Feng Liu, Ying Qin, Ying Tan, Yuyang Jiang. Zeptomolar-level one-pot simultaneous detection of multiple colorectal cancer microRNAs by cascade isothermal amplification. Biosensors and Bioelectronics 2020; 169: 112631 doi: 10.1016/j.bios.2020.112631
|
| 4 |
Soyeon Jeong, Ahmed K. Farag, Hye Kyeong Yun, Yoon A. Jeong, Dae Yeong Kim, Min Jee Jo, Seong Hye Park, Bo Ram Kim, Jung Lim Kim, Bu Gyeom Kim, Dae-Hee Lee, Eun Joo Roh, Sang Cheul Oh. AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer Cells. Cancers 2022; 14(13): 3043 doi: 10.3390/cancers14133043
|
| 5 |
Hendrik Kröning, Thomas Göhler, Thomas Decker, Marc Grundeis, Georgi Kojouharoff, Jörg Lipke, Dieter Semsek, Enno Moorahrend, Annette Sauer, Harald‐Robert Bruch, Rüdiger Liersch, Arnd Nusch, Ursula Vehling‐Kaiser, Manfred Welslau, Ralf Grunewald, Hanns‐Detlev Harich, Marcel Stephany, Jens Uhlig, Rebecca de Buhr, Melanie Frank, Cathrin Hogrefe, Norbert Marschner, Karin Potthoff, Frank Hartmann, Timo Reisländer, Ingo Schwaner. Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real‐world data from the noninterventional TACTIC study in Germany. International Journal of Cancer 2023; 153(6): 1227 doi: 10.1002/ijc.34603
|
| 6 |
Bing-chen Chen, Shi-liang Tu, Bo-an Zheng, Quan-jin Dong, Zi-ang Wan, Qiao-qiong Dai. Schizandrin A exhibits potent anticancer activity in colorectal cancer cells by inhibiting heat shock factor 1. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20200203
|
| 7 |
Omayma Mazouji, Abdelhak Ouhajjou, Roberto Incitti, Hicham Mansour. Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.660924
|
| 8 |
Mercedes Bermúdez, Maribel Aguilar-Medina, Erik Lizárraga-Verdugo, Mariana Avendaño-Félix, Erika Silva-Benítez, Cesar López-Camarillo, Rosalío Ramos-Payán. LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01008
|
| 9 |
Mai F. Tolba. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors. International Journal of Cancer 2020; 147(11): 2996 doi: 10.1002/ijc.33056
|
| 10 |
Wentian Wang, Lu Zhang, Lorraine Morlock, Noelle S. Williams, Jerry W. Shay, Jef K. De Brabander. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC). Journal of Medicinal Chemistry 2019; 62(10): 5217 doi: 10.1021/acs.jmedchem.9b00532
|
| 11 |
Fernanda Andrade, Diana Rafael, Mireia Vilar-Hernández, Sara Montero, Francesc Martínez-Trucharte, Joaquin Seras-Franzoso, Zamira V. Díaz-Riascos, Ana Boullosa, Natalia García-Aranda, Patricia Cámara-Sánchez, Diego Arango, Marika Nestor, Ibane Abasolo, Bruno Sarmento, Simó Schwartz. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. Journal of Controlled Release 2021; 331: 198 doi: 10.1016/j.jconrel.2021.01.022
|
| 12 |
Man Ju, Honggang Cheng, Kai Qu, Xiangqian Lu. Efficacy and safety of ramucirumab treatment in patients with advanced colorectal cancer. Medicine 2020; 99(24): e20618 doi: 10.1097/MD.0000000000020618
|
| 13 |
Tayebeh Cheraghi-shavi, Razieh Jalal, Zarrin Minuchehr, Lay-Hong Chuah. TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. PLOS ONE 2023; 18(8): e0289535 doi: 10.1371/journal.pone.0289535
|
| 14 |
Ikhwan Rinaldi, Kevin Winston, Leroy David Vincent, Abdillah Wicaksono, Muhammad Prasetio Wardoyo, Yusuf Aji Samudera Nurrobi, Jessica Leoni. Overall Survival and Progression-Free Survival Comparison of Bevacizumab Plus Chemotherapy Combination Regiment versus Chemotherapy Only Regiment in Previously Untreated Metastatic Colorectal Cancer: Systematic Review and Meta-Analysis. Open Access Macedonian Journal of Medical Sciences 2022; 10(F): 269 doi: 10.3889/oamjms.2022.9375
|
| 15 |
Maria Pelullo, Sabrina Zema, Mariangela De Carolis, Samantha Cialfi, Maria Valeria Giuli, Rocco Palermo, Carlo Capalbo, Giuseppe Giannini, Isabella Screpanti, Saula Checquolo, Diana Bellavia. 5FU/Oxaliplatin-Induced Jagged1 Cleavage Counteracts Apoptosis Induction in Colorectal Cancer: A Novel Mechanism of Intrinsic Drug Resistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.918763
|
| 16 |
Parvez Khan, Nivetha Sarah Ebenezer, Jawed Akhtar Siddiqui, Shailendra Kumar Maurya, Imayavaramban Lakshmanan, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser. MicroRNA-1: Diverse role of a small player in multiple cancers. Seminars in Cell & Developmental Biology 2022; 124: 114 doi: 10.1016/j.semcdb.2021.05.020
|
| 17 |
G. Wang, Y. He, Y. Sun, W. Wang, X. Qian, X. Yu, Y. Pan. Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer. Clinical and Translational Oncology 2020; 22(6): 813 doi: 10.1007/s12094-019-02213-9
|
| 18 |
Zhongqiang Zhang, Xiao Tan, Jing Luo, Beibei Cui, Sanlin Lei, Zhongzhou Si, Liangfang Shen, Hongliang Yao. Retracted: GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF‐κB signaling pathway in colorectal cancer cells. Cancer Medicine 2018; 7(11): 5611 doi: 10.1002/cam4.1783
|
| 19 |
Meng-Yan Wang, Yu-Han Qiu, Mei-Lian Cai, Cong-Hui Zhang, Xiao-Wei Wang, Hong Liu, Yi- Chen, Wu-Li Zhao, Jing-Bo Liu, Rong-Guang Shao. Role and molecular mechanism of stem cells in colorectal cancer initiation. Journal of Drug Targeting 2020; 28(1): 1 doi: 10.1080/1061186X.2019.1632317
|
| 20 |
Fei Yao, Xiaochen Xiang, Chuanren Zhou, Qiyou Huang, Xiaoying Huang, Zhufu Xie, Qiang Wang, Qingming Wu. Identification of Circular RNAs Associated With Chemoresistance in Colorectal Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.696948
|
| 21 |
Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Ciriaco Carru, Alberto Porcu, Paolo Cossu-Rocca, Maria Rosaria De Miglio. A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer. Medicina 2021; 57(11): 1257 doi: 10.3390/medicina57111257
|
| 22 |
Erika Durinikova, Kristi Buzo, Sabrina Arena. Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01981-z
|
| 23 |
Daniel-Clement Osei-Bordom, Sivesh Kamarajah, Niki Christou. Colorectal Cancer, Liver Metastases and Biotherapies. Biomedicines 2021; 9(8): 894 doi: 10.3390/biomedicines9080894
|
| 24 |
Anastasios T. Mitsakos, William Irish, Alexander A. Parikh, Rebecca A. Snyder, Girijesh Kumar Patel. The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer. PLOS ONE 2022; 17(2): e0263818 doi: 10.1371/journal.pone.0263818
|
| 25 |
Chunhong Xu, Xinxin Guo, Changhui Zhou, Hualing Zhang. Brucea javanica oil emulsion injection (BJOEI) as an adjunctive therapy for patients with advanced colorectal carcinoma. Medicine 2020; 99(27): e21155 doi: 10.1097/MD.0000000000021155
|
| 26 |
Chen-Chen Huang, Fang-Rui Liu, Qiang Feng, Xin-Yan Pan, Shu-Ling Song, Ju-Lun Yang. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08056-4
|
| 27 |
HJ Li, YL Wang, L Ming, XQ Guo, YL Li, JC Wang, YQ Zhang, L Cheng. Development of a prognostic model based on an immunogenomic landscape analysis of colorectal cancer. Future Oncology 2021; 17(3): 301 doi: 10.2217/fon-2020-0022
|
| 28 |
Johan Gagnière, Aurélien Dupré, Sepideh S. Gholami, Denis Pezet, Thomas Boerner, Mithat Gönen, Thomas P. Kingham, Peter J. Allen, Vinod P. Balachandran, Ronald P. De Matteo, Jeffrey A. Drebin, Rona Yaeger, Nancy E. Kemeny, William R. Jarnagin, Michael I. D’Angelica. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?. Annals of Surgery 2020; 271(1): 147 doi: 10.1097/SLA.0000000000002968
|
| 29 |
Guido Giordano, Pietro Parcesepe, Giuseppina Bruno, Annamaria Piscazzi, Vincenzo Lizzi, Andrea Remo, Massimo Pancione, Mario Rosario D’Andrea, Elena De Santis, Luigi Coppola, Michele Pietrafesa, Alberto Fersini, Antonio Ambrosi, Matteo Landriscina. Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era. International Journal of Molecular Sciences 2021; 22(14): 7717 doi: 10.3390/ijms22147717
|
| 30 |
Nikhil Chauhan, Mary F Mulcahy, Riad Salem, Al B Benson III, Eveline Boucher, Janet Bukovcan, David Cosgrove, Chantal Laframboise, Robert J Lewandowski, Fayaz Master, Bassel El-Rayes, Jonathan R Strosberg, Daniel Y Sze, Ricky A Sharma. TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial. JMIR Research Protocols 2019; 8(1): e11545 doi: 10.2196/11545
|
| 31 |
T.W. van de Geest, M.J. van Amerongen, P.M.H. Nierop, D.J. Höppener, D.J. Grünhagen, A. Moelker, J.J. Fütterer, C. Verhoef, J.H.W. de Wilt. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases. European Journal of Surgical Oncology 2022; 48(6): 1368 doi: 10.1016/j.ejso.2022.01.008
|
| 32 |
Xianzhe Yu, Lingling Zhu, Jiewei Liu, Ming Xie, Jiang Chen, Jianguo Li. <p>Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis</p>. OncoTargets and Therapy 2020; : 11645 doi: 10.2147/OTT.S271955
|
| 33 |
Marta Jaén, Rubén A. Bartolomé, Carmen Aizpurua, Ángela Martin-Regalado, J. Ignacio Imbaud, J. Ignacio Casal. Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies. Cancers 2021; 13(7): 1731 doi: 10.3390/cancers13071731
|
| 34 |
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Javier González-Gallego, José L. Mauriz. Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers. Experimental & Molecular Medicine 2019; 51(9): 1 doi: 10.1038/s12276-019-0308-1
|
| 35 |
Laurence Gau, Mathieu Ribeiro, Bruno Pereira, Karine Poirot, Aurélien Dupré, Denis Pezet, Johan Gagnière. Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis. European Journal of Surgical Oncology 2021; 47(11): 2722 doi: 10.1016/j.ejso.2021.05.039
|
| 36 |
Rebecca A. Shuford, Ashley L. Cairns, Omeed Moaven. Precision Approaches in the Management of Colorectal Cancer: Current Evidence and Latest Advancements towards Individualizing the Treatment. Cancers 2020; 12(11): 3481 doi: 10.3390/cancers12113481
|
| 37 |
Julien Taieb, Andreas Jung, Andrea Sartore-Bianchi, Marc Peeters, Jenny Seligmann, Aziz Zaanan, Peter Burdon, Clara Montagut, Pierre Laurent-Puig. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer. Drugs 2019; 79(13): 1375 doi: 10.1007/s40265-019-01165-2
|
| 38 |
María Belén Novoa Díaz, Pedro Matías Carriere, María Julia Martín, Natalia Calvo, Claudia Gentili. Involvement of parathyroid hormone-related peptide in the aggressive phenotype of colorectal cancer cells. World Journal of Gastroenterology 2021; 27(41): 7025-7040 doi: 10.3748/wjg.v27.i41.7025
|
| 39 |
Daniel Sur, Cristina Lungulescu, Elena Adriana Dumitrescu, Vlad Afrăsânie, Ștefan Spînu, Cristian Virgil Lungulescu, Hans- Joachim Schmoll. A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer. Expert Review of Anticancer Therapy 2023; 23(6): 633 doi: 10.1080/14737140.2023.2207830
|
| 40 |
Mengling Li, Ming Lu, Jun Li, Qingqing Gui, Yibin Xia, Chao Lu, Hongchun Shu. Classification of molecular subtypes for colorectal cancer and development of a prognostic model based on necroptosis-related genes. Heliyon 2024; 10(5): e26781 doi: 10.1016/j.heliyon.2024.e26781
|
| 41 |
E. Titmuss, K. Milne, M. R. Jones, T. Ng, J. T. Topham, S. D. Brown, D. F. Schaeffer, S. Kalloger, D. Wilson, R. D. Corbett, L. M. Williamson, K. Mungall, A. J. Mungall, R. A. Holt, B. H. Nelson, S. J. M. Jones, J. Laskin, H. J. Lim, M. A. Marra. Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. International Journal of Molecular Sciences 2023; 24(6): 5869 doi: 10.3390/ijms24065869
|
| 42 |
Francis Yew Fu Tieng, Rashidah Baharudin, Nadiah Abu, Ryia-Illani Mohd Yunos, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00135
|
| 43 |
Antonios Gargalionis, Efthimia Basdra, Athanasios Papavassiliou. Polycystins in Colorectal Cancer. International Journal of Molecular Sciences 2018; 20(1): 104 doi: 10.3390/ijms20010104
|
| 44 |
Zhenqiang Sun, Qiuge Zhang, Weitang Yuan, Xiaoli Li, Chen Chen, Yaxin Guo, Bo Shao, Qin Dang, Quanbo Zhou, Qisan Wang, Guixian Wang, Jinbo Liu, Quancheng Kan. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01705-9
|
| 45 |
Junjun Chen, Jie Dai, Zhiming Kang, Ting Yang, Qi Zhao, Jinxiu Zheng, Xinxin Zhang, Jisheng Zhang, Jun Xu, Gongqin Sun, Lijun Yang, Tao Yang. A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer. Experimental Cell Research 2020; 393(1): 112060 doi: 10.1016/j.yexcr.2020.112060
|
| 46 |
Ana‐Marija Grisic, Akash Khandelwal, Mauro Bertolino, Wilhelm Huisinga, Pascal Girard, Charlotte Kloft. Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study. CPT: Pharmacometrics & Systems Pharmacology 2020; 9(11): 628 doi: 10.1002/psp4.12558
|
| 47 |
Karishma M. Parikh, Rajiv S. Magge. Central Nervous System Metastases. 2020; : 245 doi: 10.1007/978-3-030-42958-4_17
|
| 48 |
Chen Yang, Yifan Zhang, Nelly Segar, Changhao Huang, Pengwei Zeng, Xiangzhou Tan, Linfeng Mao, Zhikang Chen, Felix Haglund, Olle Larsson, Zihua Chen, Yingbo Lin. Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer. Oncology Reports 2021; 46(2) doi: 10.3892/or.2021.8119
|
| 49 |
Kota Ouchi, Shin Takahashi, Akira Okita, Yasuhiro Sakamoto, Osamu Muto, Kenji Amagai, Takaho Okada, Hisatsugu Ohori, Eiji Shinozaki, Chikashi Ishioka. A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer. Cancer Science 2022; 113(3): 1057 doi: 10.1111/cas.15252
|
| 50 |
Steven Y. Huang, Ching-Wei D. Tzeng, Armeen Mahvash. Colorectal Liver Metastasis. 2022; : 397 doi: 10.1007/978-3-031-09323-4_43
|
| 51 |
Zi-Nan Li, Lin Zhao, Li-Feng Yu, Min-Jie Wei.
BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy. Gastroenterology Report 2020; 8(3): 192 doi: 10.1093/gastro/goaa022
|
| 52 |
Kai Zimmer, Florian Kocher, Gilbert Spizzo, Mohamed Salem, Guenther Gastl, Andreas Seeber. Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies. Computational and Structural Biotechnology Journal 2019; 17: 447 doi: 10.1016/j.csbj.2019.03.012
|
| 53 |
Yulin Lu, Qunshan Liu, Bangguo Fu, Pan Li, Weiping Xu. Label-free MIP-SERS biosensor for sensitive detection of colorectal cancer biomarker. Talanta 2023; 258: 124461 doi: 10.1016/j.talanta.2023.124461
|
| 54 |
Hae Rim Jung, Yumi Oh, Deukchae Na, Seoyeon Min, Jinjoo Kang, Dongjun Jang, Seungjae Shin, Jiwon Kim, Sang Eun Lee, Eui Man Jeong, Joon Yong An, Chang Ohk Sung, Won-Suk Lee, Charles Lee, Sung-Yup Cho. CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers. Oncogene 2021; 40(18): 3287 doi: 10.1038/s41388-021-01777-7
|
| 55 |
Yuehui Guo, Qingyun Zhu, Shiwei Chen, Yanxiang Li, Daiquan Fu, Delin Qiao, Caifang Ni. Post-transcriptional suppression of G protein-coupled receptor 15 (GPR15) by microRNA-1225 inhibits proliferation, migration, and invasion of human colorectal cancer cells. 3 Biotech 2021; 11(3) doi: 10.1007/s13205-021-02682-2
|
| 56 |
Octav Ginghina, Ariana Hudita, Marius Zamfir, Andrada Spanu, Mara Mardare, Irina Bondoc, Laura Buburuzan, Sergiu Emil Georgescu, Marieta Costache, Carolina Negrei, Cornelia Nitipir, Bianca Galateanu. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.856575
|
| 57 |
Alena Opattova, Josef Horak, Sona Vodenkova, Klara Kostovcikova, Andrea Cumova, Peter Macinga, Natalie Galanova, Alexandra Rejhova, Ludmila Vodickova, Katarina Kozics, Karolina Turnovcova, Tomas Hucl, Daniel Sliva, Pavel Vodicka. Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 845: 403065 doi: 10.1016/j.mrgentox.2019.06.001
|
| 58 |
Ruiyun Wu, Nan Shang, Meng Gui, Jian Yin, Pinglan Li. Sturgeon (Acipenser)-Derived Chondroitin Sulfate Suppresses Human Colon Cancer HCT-116 Both In Vitro and In Vivo by Inhibiting Proliferation and Inducing Apoptosis. Nutrients 2020; 12(4): 1130 doi: 10.3390/nu12041130
|
| 59 |
Maryam Balibegloo, Nima Rezaei. Development and clinical application of bispecific antibody in the treatment of colorectal cancer. Expert Review of Clinical Immunology 2020; 16(7): 689 doi: 10.1080/1744666X.2020.1783249
|
| 60 |
Eric Van Cutsem, Caroline Paccard, Marielle Chiron, Josep Tabernero. Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial. Clinical Cancer Research 2020; 26(3): 717 doi: 10.1158/1078-0432.CCR-19-1985
|
| 61 |
Christian Marx, Jürgen Sonnemann, Mandy Beyer, Oliver D. K. Maddocks, Sergio Lilla, Irene Hauzenberger, Andrea Piée‐Staffa, Kanstantsin Siniuk, Suneetha Nunna, Lisa Marx‐Blümel, Martin Westermann, Tobias Wagner, Felix B. Meyer, René Thierbach, Christina S. Mullins, Said Kdimati, Michael Linnebacher, Francesco Neri, Thorsten Heinzel, Zhao‐Qi Wang, Oliver H. Krämer. Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells. Molecular Oncology 2021; 15(12): 3404 doi: 10.1002/1878-0261.13060
|
| 62 |
Constantin Stefani, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Remus Iulian Nica, Maria Greabu, Alexandra Ripszky Totan, Mariana Jinga. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?. International Journal of Molecular Sciences 2021; 22(19): 10260 doi: 10.3390/ijms221910260
|
| 63 |
Winnie Fong, Kenneth K. W. To. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences 2019; 76(17): 3383 doi: 10.1007/s00018-019-03134-0
|
| 64 |
Won‐Jun Jang, Sung Keun Jung, Tam Thuy Lu Vo, Chul‐Ho Jeong. Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3. Journal of Cellular and Molecular Medicine 2019; 23(2): 1106 doi: 10.1111/jcmm.14011
|
| 65 |
Li Li, Mi Yang, Rutian Li, Jing Hu, Lixia Yu, Xiaoping Qian. iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(7): 910 doi: 10.2174/1871520620666200721134919
|
| 66 |
Xiaomao Hu, Minxian Xu, Yangzhi Hu, Na Li, Lei Zhou. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration. Cell Biochemistry and Biophysics 2021; 79(2): 397 doi: 10.1007/s12013-021-00975-0
|
| 67 |
Evan Bryson, Elizabeth Sakach, Urvi Patel, Marley Watson, Kevin Hall, Amber Draper, Christine Davis, Subir Goyal, Olatunji Alese, Mehmet Akce, Walid Shaib, Bassel El-Rayes, Stephen Szabo, Christina Wu. Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review. Clinical Colorectal Cancer 2021; 20(2): 153 doi: 10.1016/j.clcc.2020.12.002
|
| 68 |
Mengting Gao, Ting Jiang, Pengcheng Li, Jie Zhang, Ke Xu, Tao Ren. Efficacy and safety of HER2-targeted inhibitors for metastatic colorectal cancer with HER2-amplified: A meta-analysis. Pharmacological Research 2022; 182: 106330 doi: 10.1016/j.phrs.2022.106330
|
| 69 |
Qingying Yan, Kai Zhang, Kaibo Guo, Shan Liu, Harpreet S Wasan, Huimin Jin, Li Yuan, Guan Feng, Fengfei Shen, Minhe Shen, Shenglin Ma, Shanming Ruan. Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study. Future Oncology 2019; 15(15): 1745 doi: 10.2217/fon-2018-0785
|
| 70 |
Kunjian Peng, Zizheng Zou, Jijia Li, Yuanzhu Xie, Zhengnan Ming, Ting Jiang, Wensong Luo, Xiyuan Hu, Yuan Nie, Ling Chen, Tiao Luo, Ting Peng, Dayou Ma, Suyou Liu, Zhi-Yong Luo. Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway. Journal of Natural Products 2023; 86(9): 2111 doi: 10.1021/acs.jnatprod.3c00276
|
| 71 |
Ruihua Xu, Wei Wang, Bo Zhu, Xiaoyan Lin, Dong Ma, Lingjun Zhu, Qingchuan Zhao, Yongzhan Nie, Xiaohong Cai, Qi Li, Weijia Fang, Hongyan Li, Ning Wang, Yun Chen, Cike Peng, Honghao Fang, Lin Shen. Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6557-5
|
| 72 |
Christopher J.M. Williams, Jenny F. Seligmann, Faye Elliott, Michael Shires, Susan D. Richman, Sarah Brown, Liping Zhang, Shalini Singh, Judith Pugh, Xiao-Meng Xu, Andrea Muranyi, Christoph Guetter, Auranuch Lorsakul, Uday Kurkure, Zuo Zhao, Jim Martin, Xingwei Wang, Kien Nguyen, Wen-Wei Liu, Dongyao Yan, Nicholas P. West, Jennifer H. Barrett, Michael Barnes, Isaac Bai, Matthew T. Seymour, Philip Quirke, Kandavel Shanmugam. Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research 2021; 27(12): 3422 doi: 10.1158/1078-0432.CCR-21-0120
|
| 73 |
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, Stefano Mariani, Clelia Donisi, Nicole Liscia, Giorgio Saba, Andrea Pretta, Mara Persano, Daniela Fanni, Dario Spanu, Francesca Balconi, Francesco Loi, Simona Deidda, Angelo Restivo, Valeria Pusceddu, Marco Puzzoni, Cinzia Solinas, Elena Massa, Clelia Madeddu, Clara Gerosa, Luigi Zorcolo, Gavino Faa, Luca Saba, Mario Scartozzi. Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging. Cancers 2024; 16(7): 1364 doi: 10.3390/cancers16071364
|
| 74 |
Xiao Tan, Zhongqiang Zhang, Hongliang Yao, Liangfang Shen. RETRACTED: Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway. Cancer Letters 2018; 436: 119 doi: 10.1016/j.canlet.2018.08.012
|
| 75 |
Che-Mai Chang, Henry Wong, Chien-Yu Huang, Wen-Li Hsu, Zhi-Feng Maio, Siou-Jin Chiu, Yao-Ting Tsai, Ben-Kuen Chen, Yu-Jui Wan, Jaw-Yuan Wang, Wei-Chiao Chang. Functional Effects of let-7g Expression in Colon Cancer Metastasis. Cancers 2019; 11(4): 489 doi: 10.3390/cancers11040489
|
| 76 |
Saade Abdalkareem Jasim, Ali A. Majeed, Herlina Uinarni, Mohammed Alshuhri, Abdullah Ali Alzahrani, Abeer A. Ibrahim, Ahmed Alawadi, Noor K. Abed Al-Abadi, Yasser Fakri Mustafa, Batool Ali Ahmed. Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms. Pathology - Research and Practice 2024; 254: 155119 doi: 10.1016/j.prp.2024.155119
|
| 77 |
Lara J. Bou Malhab, Wael M. Abdel-Rahman. Obesity and Inflammation: Colorectal Cancer Engines. Current Molecular Pharmacology 2022; 15(4): 620 doi: 10.2174/1874467214666210906122054
|